Perimeter Medical Imaging AI Completes $3.13 Million Prospectus Offering

The latest update is out from Perimeter Medical Imaging AI ( (TSE:PINK) ).

Perimeter Medical Imaging AI, Inc. has successfully closed its prospectus offering, raising approximately $3.13 million through the issuance of over 10 million units. The proceeds will support the commercialization of its technology, clinical evidence establishment, and product development. This financial move is expected to bolster Perimeter’s market position and operational capabilities, potentially enhancing its impact on the medical imaging industry.

The most recent analyst rating on (TSE:PINK) stock is a Buy with a C$3.00 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.

Spark’s Take on TSE:PINK Stock

According to Spark, TipRanks’ AI Analyst, TSE:PINK is a Neutral.

Perimeter Medical Imaging AI is positioned in a growth phase with strong revenue increases and promising clinical advancements towards FDA approval. However, persistent net losses, cash flow constraints, and bearish technical indicators pose significant challenges. The valuation remains unattractive, but recent strategic corporate events offer potential for future expansion.

To see Spark’s full report on TSE:PINK stock, click here.

More about Perimeter Medical Imaging AI

Perimeter Medical Imaging AI, Inc. is a medical technology company based in Toronto, Canada, and Dallas, Texas. It focuses on transforming cancer surgery with advanced imaging tools, offering ultra-high-resolution, real-time visualization of excised tissues. The company’s FDA-cleared Perimeter S-Series OCT system is available across the U.S., and it is developing the next-generation Perimeter B-Series OCT with ImgAssist AI.

Average Trading Volume: 83,407

Technical Sentiment Signal: Sell

Current Market Cap: C$21.51M

Find detailed analytics on PINK stock on TipRanks’ Stock Analysis page.